Beyond the Virus: The Collateral Impact of COVID-19 on Antimicrobial Consumption, Microbial Resistance, and Pharmacoeconomics
The pandemic intensified antimicrobial use, resistance, and costs. While limited by its single-center design and the use of all inpatients as the denominator, these findings highlight the important need for reinforced antimicrobial stewardship to build healthcare system resilience.
Authors
- Silvana Maria de Almeida (ORCID: https://orcid.org/0000-0002-8928-9140)
- Alessandra Gomes Chauvin (ORCID: https://orcid.org/0009-0006-4028-1152)
- Elivane da Silva Victor (ORCID: https://orcid.org/0000-0003-2550-0469)
- Tatiana Aporta Marins (ORCID: https://orcid.org/0000-0002-3125-1764)
- Alexandre Rodrigues Marra (ORCID: https://orcid.org/0000-0002-7577-7688)
- Daniel Tavares Malheiro (ORCID: https://orcid.org/0000-0003-4321-647X)
- Michael B. Edmond (ORCID: https://orcid.org/0000-0002-4144-8974)
- Roberta Greinier dos Santos
- André Luís Franco Cotia (ORCID: https://orcid.org/0000-0001-7141-5009)
- Leandro Martins dos Santos
- Alexandra R. Toniolo
- Isabele Pardo (ORCID: https://orcid.org/0009-0004-6375-4640)
- Anderson Paulo Scorsato
- Isabella L. Rosmino
- Barbara Barduchi
Institutions
- West Virginia University (US)
- Hospital Israelita Albert Einstein (BR)
- University of Iowa Health Care (US)
Publication Details
- Journal
- Pathogens
- Published
- 2025-11-05
- DOI
- https://doi.org/10.3390/pathogens14111126
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sociedade Beneficente Israelita Brasileira Albert Einstein